Innoviva Market Cap

Innoviva has a market cap or net worth of $1.56 billion as of August 6, 2026. Its market cap has increased by 34.60% in one year.

Market Cap

1.56B

Enterprise Value

1.24B

1-Year Change

34.60%

Ranking

#2304

ChartMarket Cap Chart

Chart

Since October 5, 2004, Innoviva's market cap has increased from $743.40M to $1.56B, an increase of 109.59%. That is a compound annual growth rate of 3.44%.

Market Cap History

Date	Market Cap	% Change
Aug 6, 2026	1.53B	2.04%
Dec 31, 2025	1.49B	37.61%
Dec 31, 2024	1.09B	5.65%
Dec 29, 2023	1.03B	11.18%
Dec 30, 2022	924.60M	-22.87%
Dec 31, 2021	1.20B	-4.58%
Dec 31, 2020	1.26B	-12.40%
Dec 31, 2019	1.43B	-18.66%
Dec 31, 2018	1.76B	15.03%
Dec 29, 2017	1.53B	31.74%
Dec 30, 2016	1.16B	-6.00%
Dec 31, 2015	1.24B	-24.18%
Dec 31, 2014	1.63B	-48.60%
Dec 31, 2013	3.18B	81.10%
Dec 31, 2012	1.75B	15.68%
Dec 30, 2011	1.52B	16.20%
Dec 31, 2010	1.30B	94.91%
Dec 31, 2009	669.40M	8.40%
Dec 31, 2008	617.50M	-35.48%
Dec 31, 2007	957.00M	-35.96%
Dec 29, 2006	1.49B	30.34%
Dec 30, 2005	1.15B	49.85%
Dec 31, 2004	765.10M	2.92%
Oct 5, 2004	743.40M	-

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
AnaptysBio	1.63B
Ascentage Pharma Group International	1.57B
Maze Therapeutics	1.54B
Vir Biotechnology	1.54B
Intellia Therapeutics	1.53B
Tyra Biosciences	1.53B
Xencor	1.47B
MoonLake Immunotherapeutics	1.45B

Market Cap Rankings